Pune-based Drug maker Gennova eyes nod for omicron-specific vax

India is likely to get an Omicron-specific booster shot soon. Gennova Biopharmaceuticals, subsidiary of Pune-based drug maker Emcure, will soon submit data of clinical trials conducted on its mRNA vaccine that will target the Omicron variant of...

Biological E, Bharat Biotech together are holding on stockpile of 250 million COVID vaccine doses

Two major vaccine makers from Hyderabad, Biological E Ltd and Bharat Biotech, together are holding about 250 million doses of COVID-19 vaccines ready to dispatch as and when orders are received...

Bharat Biotech's iNCOVACC to be India's 1st intranasal vaccine to cost Rs 800 in private markets, Rs 325 for govt

Bharat Biotech today announced that iNCOVACC (BBV154), will be rolled out in the fourth week of January as booster dose for those above 18 years of age in India. The intranasal vaccine which is now available on CoWin, has been priced at Rs 800 for...

Hetero gets WHO Prequalification of medicines program approval for NIRMACOM

Pharmaceuticals firm Hetero on Monday said it has received World Health Organisation Prequalification of medicines program (WHO PQ) approval for its generic version of COVID-19 oral antiviral treatment candidate 'Nirmatrelvir'. Hetero's 'NIRMACOM'...

Advent set to buy Suven Pharma for Rs 6300 cr

Advent International is expected to sign a binding agreement to buy Suven Pharmaceuticals, a Hyderabad-based listed contract research and manufacturing services (CRAMS) company, as early as Monday morning, people familiar with the matter told...

Top three trends in Veterinary pharmaceuticals market

In this article lets look into the key trends in Veterinary drugs market.

Top Three Technologies Revolutionizing the Adult Vaccine Market

The rise in number of government initiatives with an aim to avert certain diseases and epidemics are anticipated to fuel the adult vaccines market growth. Right from the invention of vaccines they have revolutionized the healthcare industry.

Alembic Pharma receives USFDA nod for Pregabalin capsules

Alembic Pharmaceuticals Limited announced that it has received PAS (Prior Approval Supplement) approval from the US Food Drug Administration (USFDA) for its supplemental Abbreviated New Drug Application (sANDA) Pregabalin capsules, 25 mg, 50 mg,...

BeatO appoints Dr Navneet Agrawal as chief clinical officer

BeatO, a comprehensive digital diabetes care platform for controlling and reversing diabetes, has announced the appointment of Dr. Navneet Agrawal as its chief clinical officer. Dr. Navneet Agrawal will head BeatO’s proprietary Diabetes Care...

C-CAMP & Netherlands Embassy in India launch WAH! Accelerator to fulfil the One Health Vision to address AMR

Centre for Cellular and Molecular Platforms (C-CAMP) an initiative supported by Department of Biotechnology is delighted to announce a next-generation Indo-Dutch bilateral collaboration to address the challenge posed by antimicrobial resistance...

© 2025 India Pharma Outlook. All Rights Reserved.